Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    Press Releases

    Press Releases

    03-30-2021
    Daré Bioscience Reports Full Year 2020 Financial Results and Provides a Company Update
    03-24-2021
    Daré Bioscience Announces Initiation of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder
    03-23-2021
    Daré Bioscience to Host Full Year 2020 Financial Results and Company Update Conference Call and Webcast on March 30, 2021
    03-22-2021
    Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-Oral, Bio-identical Hormone Therapy for the Treatment of Vasomotor Symptoms & Genitourinary Syndrome Associated with Menopause
    03-10-2021
    Daré Bioscience to Participate in Upcoming Virtual Conferences
    03-08-2021
    Daré Bioscience to Participate at the 33rd Annual Roth Conference
    03-02-2021
    Daré Bioscience to Present at the H.C. Wainwright Global Life Sciences Conference
    02-25-2021
    Daré Bioscience to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event
    02-16-2021
    Daré Bioscience to Participate at the Women’s Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021
    02-09-2021
    Daré Bioscience to Present at the 2021 BIO CEO & Investor Digital Conference

    Pagination

    • Current page 1
    • Page 2
    • Next page next ›
    • Last page last »
    Displaying 1 - 10 of 11
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2021 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top